| Unsupervised named-entity extraction from the web: An experimental study O Etzioni, M Cafarella, D Downey, AM Popescu, T Shaked, S Soderland, ... Artificial intelligence 165 (1), 91-134, 2005 | 1641 | 2005 |
| Comprehensive genomic profiling of 282 pediatric low‐and high‐grade gliomas reveals genomic drivers, tumor mutational burden, and hypermutation signatures A Johnson, E Severson, L Gay, JA Vergilio, J Elvin, J Suh, S Daniel, ... The oncologist 22 (12), 1478-1490, 2017 | 205 | 2017 |
| Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3 JS Ross, M Fakih, SM Ali, JA Elvin, AB Schrock, J Suh, JA Vergilio, ... Cancer 124 (7), 1358-1373, 2018 | 185 | 2018 |
| ALK Fusions in a Wide Variety of Tumor Types Respond to Anti‐ALK Targeted Therapy JS Ross, SM Ali, O Fasan, J Block, S Pal, JA Elvin, AB Schrock, J Suh, ... The Oncologist 22 (12), 1444-1450, 2017 | 99 | 2017 |
| Informed consent for blood transfusion: what do medicine residents tell? What do patients understand? M Friedman, W Arja, R Batra, S Daniel, D Hoehn, AM Paniz, S Selegean, ... American journal of clinical pathology 138 (4), 559-565, 2012 | 98 | 2012 |
| Genomic characterization of testicular germ cell tumors relapsing after chemotherapy A Necchi, G Bratslavsky, RJ Corona, JH Chung, SZ Millis, JA Elvin, ... European urology focus 6 (1), 122-130, 2020 | 42 | 2020 |
| Abstract P2-09-15: NTRK fusions in breast cancer: Clinical, pathologic and genomic findings JS Ross, J Chung, JE Elvin, JA Vergilio, S Ramkissoon, J Suh, ... Cancer Research 78 (4_Supplement), P2-09-15-P2-09-15, 2018 | 30 | 2018 |
| Landscape Of Genomic Alterations (GA) And Tumor Mutational Burden (TMB) In Different Metastatic Melanoma (MM) Subtypes. DB Johnson, JA Carlson, JA Elvin, JA Vergilio, J Suh, S Ramkissoon, ... Journal of Clinical Oncology 35 (15_suppl), 9536-9536, 2017 | 22 | 2017 |
| BRAF fusions in clinically advanced non-small cell lung cancer: An emerging target for anti-BRAF therapies. VP Reddy, LM Gay, JA Elvin, JA Vergilio, J Suh, S Ramkissoon, S Daniel, ... Journal of Clinical Oncology 35 (15_suppl), 9072-9072, 2017 | 19 | 2017 |
| Comprehensive Genomic Profiling (CGP) With Loss Of Heterozygosity (LOH) To Identify Therapeutically Relevant Subsets Of Ovarian Cancer (OC). JA Elvin, Y He, J Sun, K Odunsi, JB Szender, KN Moore, LM Gay, ... Journal of Clinical Oncology 35 (15_suppl), 5512-5512, 2017 | 16 | 2017 |
| BRAF: An Emerging Target for Triple-Negative Breast Cancer. J Albanell, JA Elvin, SM Ali, AB Schrock, J Chung, JA Vergilio, J Suh, ... Journal of Clinical Oncology 35 (15_suppl), 1099-1099, 2017 | 13 | 2017 |
| Immune Checkpoint Inhibitor (ICPI) Efficacy and Resistance Detected By Comprehensive Genomic Profiling (CGP) In Non-Small Cell Lung Cancer (NSCLC) JS Ross, ME Goldberg, LA Albacker, LM Gay, V Agarwala, JA Elvin, ... Annals of Oncology 28 (suppl_5), 2017 | 11 | 2017 |
| Mutational Burden of Tumors With Primary Site Unknown LM Gay, D Fabrizio, GM Frampton, CF Connelly, J Sun, S Daniel, JA Elvin, ... Journal of Clinical Oncology 35 (15_suppl), 3039-3039, 2017 | 10 | 2017 |
| Pine, and Ajay K Thapar. 2012 A Thapar, S Collishaw, S Daniel Depression in adolescence. The Lancet 379 (9820), 1056-1067, 2012 | 10 | 2012 |
| Comprehensive Genomic Profiling (CGP) of Thymic Gland Carcinomas JS Ross, P Vanden Borre, N Almog, AB Schrock, J Chung, JA Vergilio, ... Annals of Oncology 28 (suppl_5), 2017 | 9 | 2017 |
| Targeted Therapy for HER2 Driven Colorectal Cancer JS Ross, SM Ali, JA Elvin, AB Schrock, J Suh, JA Vergilio, S Ramkissoon, ... Journal of Clinical Oncology 35 (15_suppl), 3583-3583, 2017 | 9 | 2017 |
| PBRM1 mutation and immunotherapy efficacy: A comprehensive genomic profiling (CGP) assessment. G Bratslavsky, LM Gay, E Sokol, JA Elvin, JA Vergilio, J Suh, ... Journal of Clinical Oncology 36 (15_suppl), 12091-12091, 2018 | 7 | 2018 |
| Genomic Landscape of Adult and Pediatric BCR‐ABL1‐Like B‐Lymphoblastic Leukemia Using Parallel DNA and RNA Sequencing EA Severson, JA Vergilio, LM Gay, S Daniel, AC Hemmerich, JA Elvin, ... The Oncologist 24 (3), 372-374, 2019 | 6 | 2019 |
| Genomic Profiling Of 114,200 Advanced Cancers Identifies Recurrent Kinase Domain Duplications (KDD) And Oncogenic Rearrangements (RE) Across Diverse Tumor Types LM Gay, D Pavlick, J Chung, S Ramkissoon, S Daniel, JA Elvin, ... Annals of Oncology 28 (suppl_5), 2017 | 6 | 2017 |
| A Clinical and Genomic Profile Of Inflammatory Myofibroblastic Tumors S Daniel, LM Gay, JA Vergilio, JS Ross Journal of Clinical Oncology 35 (15_suppl), 1538-1538, 2017 | 6 | 2017 |
